Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: An Updated Analysis of the Japan Clinical Oncology Group Study JCOG0211-Reference-Cited by-同舟云学术

Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: An Updated Analysis of the Japan Clinical Oncology Group Study JCOG0211

Published:2012-11-10 Issue:32 Volume:30 Page:4044-4046
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Yamaguchi Motoko¹,Tobinai Kensei²,Oguchi Masahiko³,Ishizuka Naoki⁴,Kobayashi Yukio²,Isobe Yasushi⁵,Ishizawa Kenichi⁶,Maseki Nobuo⁷,Itoh Kuniaki⁸,Usui Noriko⁹,Wasada Izumi¹⁰,Kinoshita Tomohiro¹¹,Hotta Tomomitsu¹²,Tsukasaki Kunihiro¹³,Oshimi Kazuo¹⁴

Affiliation:

1. Mie University Graduate School of Medicine, Tsu, Japan

2. National Cancer Center Hospital, Tokyo, Japan

3. Japanese Foundation for Cancer Research Cancer Institute Hospital, Tokyo, Japan

4. National Center of Global Health and Medicine, Tokyo, Japan

5. Juntendo University School of Medicine, Tokyo, Japan

6. Tohoku University Hospital, Sendai, Japan

7. Saitama Cancer Center, Ina, Japan

8. National Cancer Center Hospital East, Kashiwa, Japan

9. Jikei University School of Medicine, Tokyo, Japan

10. Tokai University, Isehara, Japan

11. Aichi Cancer Center Hospital, Nagoya, Japan

12. National Hospital Organization Nagoya Medical Center, Nagoya, Japan

13. Nagasaki University Graduate School of Medicine, Nagasaki, Japan

14. Eisai, Tokyo, Japan

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2012.45.6541

Reference6 articles.

1. ES Jaffe, NL Harris, H Stein , etal : World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2001 Lyon, France IARC Press

2. SH Swerdlow, E Campo, NL Harris , etal : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 Lyon, France IARC

3. Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211

4. Angiocentric Lymphoma of the Head and Neck: Patterns of Systemic Failure After Radiation Treatment

5. Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas;Haematologica;2023-11-21

2. Efficacy of Frontline Chemotherapy for Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Network Meta-Analysis;Journal of Hematology;2023-10

3. Outcomes and prognostic factors of patients with Extranodal NK T cell lymphoma (ENKTL);Leukemia & Lymphoma;2023-08-21

4. Radioterapia en linfoma de células T/<i>natural killer</i> tipo nasal primario cutáneo;Gaceta Mexicana de Oncolog�a;2023-07-25

5. Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?;Frontiers in Oncology;2023-07-17